Effect of obesity on high-density lipoprotein metabolism (Q37058273)

18 August 2017

1 reference

title

Effect of obesity on high-density lipoprotein metabolism (English)

1 reference

18 August 2017

0 references

1 reference

Shirya Rashid

1

1 reference

PubMed ID

18198293

18 August 2017

Jacques Genest

series ordinal

2

1 reference

18 August 2017

1 December 2007

1 reference

18 August 2017

1 reference

18 August 2017

15

1 reference

18 August 2017

12

1 reference

18 August 2017

2875-2888

1 reference

Two novel missense mutations in ABCA1 result in altered trafficking and cause severe autosomal recessive HDL deficiency.

18 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

The associations of high-density lipoprotein subclasses with insulin and glucose levels, physical activity, resting heart rate, and regional adiposity in men with coronary artery disease: the Stanford Coronary Risk Intervention Project baseline surv

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

The ratio of waist-to-hip circumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL2 cholesterol level in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

The Effects on Plasma Lipoproteins of a Prudent Weight-Reducing Diet, with or without Exercise, in Overweight Men and Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Cardiovascular Changes After Weight Reduction in Obesity Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Molecular regulation of HDL metabolism and function: implications for novel therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Subjects with ApoA-I(Lys107-->0) exhibit enhanced fractional catabolic rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI with AII)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Point mutations in apolipoprotein A-I mimic the phenotype observed in patients with classical lecithin:cholesterol acyltransferase deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Familial HDL deficiency due to marked hypercatabolism of normal apoA-I

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

The relationship of high density lipoprotein subfractions to alcohol consumption, other lifestyle factors, and coronary heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Targeting low high-density lipoprotein cholesterol for therapy: lessons from the Veterans Affairs High-density Lipoprotein Intervention Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Strategies and potential molecular targets for obesity treatment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Application of weight-height ratios and body indices to juvenile populations--the National Health Examination Survey Data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

High-density lipoprotein as a therapeutic target: clinical evidence and treatment strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Adiposity, fat distribution, and cardiovascular risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: Normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Adipose tissue distribution and plasma lipoprotein levels in obese women. Importance of intra-abdominal fat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Relation of body fat distribution to metabolic complications of obesity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Visceral Adipose Tissue Cutoffs Associated With Metabolic Risk Factors for Coronary Heart Disease in Women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Modification of the relationship between simple anthropometric indices and risk factors by ethnic background

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Low high density lipoprotein-2 concentrations in obese male subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Plasma high density lipoproteins. Metabolism and relationship to atherogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Insulin resistance and cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Letting lipids go: hormone-sensitive lipase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Effects of weight reduction on plasma lipoproteins and adipose tissue metabolism in obese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Crystal structure of CETP: new hopes for raising HDL to decrease risk of cardiovascular disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

The withdrawal of torcetrapib from drug development: implications for the future of drugs that alter HDL metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Evidence that endothelial lipase remodels high density lipoproteins without mediating the dissociation of apolipoprotein A-I

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Visceral adiposity and endothelial lipase.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Adipocyte lipases and defect of lipolysis in human obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Transformation of high density lipoprotein 2 particles by hepatic lipase and phospholipid transfer protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Effects of weight loss on PLTP activity and HDL particle size

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Does weight loss cause the exercise-induced increase in plasma high density lipoproteins?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Characterization of high density lipoprotein binding to human adipocyte plasma membranes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

The independent effects of dietary weight loss and aerobic training on high density lipoproteins and apolipoprotein A-I concentrations in obese men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Obesity and lipoprotein cholesterol in the Framingham offspring study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Effects of high density lipoprotein subfractions on cholesterol homeostasis in human fibroblasts and arterial smooth muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

High-density lipoprotein apolipoprotein A-I kinetics in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

New insights into the biogenesis of human high-density lipoproteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Influence of obesity and insulin sensitivity on phospholipid transfer protein activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Drug treatments for obesity: orlistat, sibutramine, and rimonabant.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18–0647 (tetrahydrolipstatin)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Influence of weight reduction on plasma lipoproteins in obese patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Early and late effects of weight loss on lipoprotein metabolism in severe obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanisti

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Effects of a vigorous walking program on body composition, and carbohydrate and lipid metabolism of obese young men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Effects of physical activity on weight reduction in obese middle-aged women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

What do muscles have to do with lipoproteins?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Changes in plasma lipid and lipoprotein levels in men and women after a program of moderate exercise

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

The effect of acute exercise on high density lipoprotein-cholesterol and the subfractions in females

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Acute increase in lipoprotein lipase following prolonged exercise

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

The effects of exercise and weight loss on plasma lipids in young obese men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Lipoprotein metabolism influenced by training-induced changes in human skeletal muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Increase of adipose tissue lipoprotein lipase activity with weight loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Serum lipoproteins in overweight/obese postmenopausal women: a one-year exercise trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

The effect of combined aerobic and resistance exercise training on abdominal fat in obese middle-aged women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

The effects of running mileage and duration on plasma lipoprotein levels.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Weight set-point theory and the high-density lipoprotein concentrations of long-distance runners

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Effect of prolonged exercise training without weight loss on high-density lipoprotein metabolism in overweight men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Modest changes in high-density lipoprotein concentration and metabolism with prolonged exercise training

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Gemfibrozil, lipids, and coronary risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

Exercise applications and promotion in behavioral medicine: current status and future directions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.342

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2007.342

1 reference

18 August 2017

1 reference

PubMed ID

18198293